Technology to Reduce Infections

Steriwave™ Nasal Decolonization (ND), also known as MRSAid, is a broad-spectrum antimicrobial providing targeted decolonization safely, effectively, quickly.

  • Broad-spectrum: Kills all pathogens (bacterial, viral, fungal).

  • Non-resistance forming.

  • Safe and painless treatment for patients within 5 minutes.

  • High compliance, clinician administered.

  • Suitable for repetitive use (e.g. healthcare workers, frequent hospital visitors, long-term care facilities, outpatients, dialysis patients).

Photodisinfection eliminates topical pathogens rapidly and does not generate resistance.  It is a highly effective antimicrobial that targets bacterial biofilm, virus, yeasts and fungi without harming human tissue.


Not available for sale in the US.

Kill Germs Living in the Nose in Minutes

A photosensitive agent activated by a specific wavelength of nonthermal light, causes rapid microbial kill through physical disruption of the microbial cell membrane.

Steriwave ND works by rapidly destroying microbes upon light activation.  The pathogens are unable to adapt to this treatment, eliminating the concern of antimicrobial resistance.

Real World Results

Canadian hospitals implemented our photodisinfection technology for orthopedic, spinal, and several other surgical
specialties with compelling results in the first year*.

  • 42% surgical site infection reduction.

  • CAD $1.9M costs avoided + 552 bed-days saved.

  • 3,068 surgical patients decolonized during initial year.

  • 94% compliance with decolonization.

  • 3.7x reduction in surgical site infection (SSI) risk (P=0.00026).

Since 2011, Steriwave ND has become a key component of the hospital’s surgical infection control efforts that, together with NSQIP and additional surgical bundles added in the intervening years, have led to the hospital reducing its overall SSI rate to 0.6%.

* Bryce E, Wong T, Forrester L, et al. Nasal photodisinfection and chlorhexidine wipes decrease surgical site infections: a historical control study and propensity analysis. J Hosp Infect. 2014 Oct;88(2):89-95.

Steriwave ND’s user-friendly technology is well-received by nurses and patients alike with over
8,000 surgical patients decolonized annually.


Steriwave ND is not available for sale in the US.

Upcoming Events

Quality Forum 2020

February 25 - February 27

Vancouver, BC Canada

Whistler, BC Canada

London, United Kingdom

Quick Links


Light Years Ahead

Committed to providing simple solutions to complex infections.

Contact Us
Share this post via Email
Share this post on Twitter
Share this post on LinkedIn
Print PDF of this post